Credit Agricole’s Vivos Therapeutics VVOS Stock Holding History

Credit Agricole’s Portfolio VVOS Stock Details VVOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$6.74K	Hold	2,365	–	–	﹤0.01%	1222
2024 Q4	$10.1K	Hold	2,365	–	–	﹤0.01%	1233
2024 Q3	$6.17K	Hold	2,365	–	–	﹤0.01%	1227
2024 Q2	$5.25K	Hold	2,365	–	–	﹤0.01%	1063
2024 Q1	$63	Hold	2,365	–	–	﹤0.01%	940
2023 Q4	$294	Buy	2,365 +1	+0%	+$9	﹤0.01%	893
2023 Q3	$11.4K	Hold	2,364	–	–	﹤0.01%	845
2023 Q2	$30.1K	Hold	2,364	–	–	﹤0.01%	569
2023 Q1	$20.2K	Hold	2,364	–	–	﹤0.01%	557
2022 Q4	$23.8K	Hold	2,364	–	–	﹤0.01%	575
2022 Q3	$38K	Hold	2,364	–	–	﹤0.01%	534
2022 Q2	$76K	Hold	2,364	–	–	﹤0.01%	483
2022 Q1	$158K	Hold	2,364	–	–	﹤0.01%	436
2021 Q4	$133K	Hold	2,364	–	–	﹤0.01%	452
2021 Q3	$239K	Buy	+2,364	New	+$248K	﹤0.01%	374

Other funds holding VVOS

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Credit Agricole's VVOS Position: Q1 2025 in Review

Credit Agricole held its Vivos Therapeutics (VVOS) position steady in Q1 2025 at 2,365 shares worth $6.74K. The position accounts for ﹤0.01% of the portfolio, ranked #1222.

Credit Agricole first reported a position in VVOS in Q3 2021 and has held it in 15 quarters since. The position peaked at $239K in Q3 2021. 20 funds tracked by Wall St. Rank hold VVOS as of Q1 2025.

Credit Agricole held 2,365 shares of Vivos Therapeutics worth $6.74K as of Q1 2025.
Credit Agricole left its Vivos Therapeutics share count unchanged in Q1 2025.
Vivos Therapeutics made up ﹤0.01% of Credit Agricole's portfolio in Q1 2025, its #1222 holding.
Credit Agricole first reported a position in Vivos Therapeutics in Q3 2021 and has held it in 15 quarters since.
Credit Agricole's Vivos Therapeutics position peaked at $239K in Q3 2021.
20 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q1 2025.

Based on Credit Agricole's 13F filing for Q1 2025, filed 14 May 2025.